Variation Application For Biological Products

User Rating: 1 / 5

Star ActiveStar InactiveStar InactiveStar InactiveStar Inactive
 

16.1.3 VARIATION APPLICATION FOR BIOLOGICAL PRODUCTS

Variation application for biologics shall follow the Malaysian Variation Guidelines for Biologics (MVGB) as stated in the directive issued by Director of Pharmaceutical Services under Regulation 29, CDCR 1984; Directive No. 2 Year 2017. Ref: BPFK/PPP/07/25(7)Jld.1: Direktif Untuk Melaksanakan Malaysian Variation Guideline For Biologics (MVGB)

The MVGB will serve as a main document for all variation applications.  The MVG will serve as a secondary document for all administrative changes.  If there are variations that are not covered in both MVGB and MVG, the PRH should determine the classification of change based on a change-specific risk assessment using the principles and examples that have been set out in the MVGB.  Please refer to section 3.0 (General Considerations) of the MVGB for further details.

 All applications submitted either via the QUEST3+ system or manually shall be accompanied by a cover letter, of which the content of the cover letter shall be in accordance to 4.1.2 and 4.1.3 of the MVGB.

National Pharmaceutical Regulatory Agency (NPRA)
Lot 36, Jalan Universiti, 46200 Petaling Jaya, Selangor, Malaysia.
  • Email: npra@npra.gov.my
  • Phone: +603-7883 5400
  • Fax: +603-7956 2924, +603-7956 7075

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

Newsletter Subsription

Error : Please select some lists in your AcyMailing module configuration for the field "Automatically subscribe to" and make sure the selected lists are enabled

Site Last Modified

  • Last Modified: Thursday 19 September 2019, 09:59:51.
© Copyright 2019 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA

Main Menu English

Choose Your Language